Synthesis and biological activities of new hydrazide derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 3, 2009, Pages 825-831

  Özdemir, Ahmet ^a   Turan Zitouni, Gulhan ^a   Kaplancikli, Zafer Asim ^a   Tunali, Yaǧmur ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Antituberculosis activity; Hydrazide; Imidazo 1,2 a pyrazine

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ETHYLIMIDAZO[1,2 A]PYRAZINE 2 CARBOXYLATE; HYDRAZIDE DERIVATIVE; IMIDAZO[1,2 A]PYRAZINE 2 CARBOXYLIC ACID ARYLIDENE HYDRAZIDE DERIVATIVE; IMIDAZO[1,2 A]PYRAZINE 2 CARBOXYLIC ACID HYDRAZIDE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; HYDRAZINE DERIVATIVE; IMIDAZOLE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; CANDIDA GLABRATA; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUNGUS ISOLATION; INFRARED RADIATION; INFRARED SPECTROSCOPY; KLEBSIELLA; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEUS VULGARIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; RADIOMETRY; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; BACTERIA; CHEMISTRY; DRUG EFFECTS; FUNGUS; HUMAN; MICROBIAL SENSITIVITY TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TURKEY;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; CANDIDA GLABRATA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUNGI; KLEBSIELLA; MYCOBACTERIUM TUBERCULOSIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; BACTERIA; FUNGI; HUMANS; HYDRAZINES; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TURKEY;

EID: 70249148323     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802399712     Document Type: Article

References (29)

1. Kim SW, Kuti JL, Nicolau DP. Inhaled antimicrobial therapies for respiratory infections. Curr Infect Dis Rep 2008;10:29-36.
2. Kaplancikli ZA, Turan-Zitouni G, O ̈zdemir A, Revial G, Güven K. Synthesis and antimicrobial activity of some thiazolyl-pyrazoline derivatives. Phosphorus, Sulfur, and Silicon 2007;182:749-764.
3. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12:40-79.
4. Turan-Zitouni G, Kaplancikli ZA, Özdemir A, Revial G, Güven K. Synthesis and antimicrobial activity of some 2- (benzo[d]oxazol/benzo[d] imidazol-2-ylthio)-N-(9H-fluoren- 9-yl)acetamide derivatives. Phosphorus, Sulfur, and Silicon 2007;182:639-646.
5. Hood S, Denning DW. Treatment of fungal infection in AIDS. J Antimicrob Chemother 1996;37:71-85.
6. Alexander BD, Perfect JR. Antifungal resistance trends towards the year 2000: Implications for therapy and new approaches. Drugs 1997;54:657-678.
7. Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis 2003;83:4-14.
8. Churchyard GJ, Grant AD. HIV infection, tuberculosis and nontuberculousmycobacteria. South African Med J 2000;91: 472-476.
9. Benson CA. Mycobacterium tuberculosis and Mycobacterium avium complex disease in patients with HIV infection. Curr Opin Infect Dis 1994;7:95-107.
10. Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005;45:529-564.
11. Guardiola-Diaz HM, Foster LA, Mushrush D, Vaz ADN. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: Implications for treatment of tuberculosis. Biochem Pharmacol 2001;61:1463-1470.
12. McLean KJ, Marshall KR, Richmond A, Hunter IS, Fowler K, Kieser T, Gurcha SS, Besra GS, Munro AW. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology-SGM 2002;148:2937-2949.
13. McLean KJ, Cheesman MR, Rivers SL, Richmond A, Leys D, Chapman SK, Reid GA, Price NC, Kelly SM, Clarkson J, Smith WE, Munro AW. Expression, purification and spectroscopic characterization of the cytochrome P450CYP121 from Mycobacterium tuberculosis. J Inorg Biochem 2002;91:527-541.
14. Mowat GC, Leys D, McLean KJ, Rivers SL, Richmond A, MunroAW,LombardiaMO, AlzariPM,ReidGA,ChapmanSK, Walkinshaw MD. Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis. Acta Cryst 2002;D58:704-705.
15. Munro AW, McLean KJ, Marshall KR, Warman AJ, Lewis G, Roitel O, Sutcliffe MJ, Kemp CA, Modi S, Scrutton NS, Leys D. Cytochromes P450: Novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Biochem Soc Trans 2003;31:625-630.
16. Menozzi G, Merello L, Fossa P, Schenone S, Ranise A, Mosti L, Bondavalli F, Loddo R, Murgioni C, Mascia V, La Colla P, Tamburini E. Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol- 1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles. Bioorg Med Chem 2004;12:5465-5483.
17. Vicini P, Zani F, Cozzini P, Doytchinova I. Hydrazones of 1,2- benzisothiazole hydrazides: Synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem 2002;37:553-564.
18. Metwally KA, Abdel-Aziz LM, Lashine EM, Husseiny MI, Badawy RH. Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents. Bioorg Med Chem 2006;14:8675-8682.
19. Gürsoy A, Terziog?lu N, Ötük G. Synthesis of some new hydrazide-hydrazones, thiosemicarbazides and thiazolidinones as possible antimicrobials. Eur JMed Chem 1997;32:753-757.
20. Swamy BN, Suma TK, Rao GV, Reddy GC. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis. Eur J Med Chem 2007;42:420-424.
21. Sriram D, Yogeeswari P, Devakaram RV. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Bioorg Med Chem 2006;14:3113-3118.
22. Küçükgüzel SG, Rollas S. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5- ones as potential antimycobacterial agents. Farmaco 2002;57:583-587.
23. Bonnet PA, Sablayrolles C, Chapat JP, Soulie B, Buochberg MSD, Dusart G, Attisso M. Imidazo[1,2-a]pyrazine-2- carboxamidrazones-synthesis and anti-bacterial activity. Eur J Med Chem 1983;18:413-417.
24. Abignente E, Arena F, De Caprariis P, Nuzetti R, Marmo E, Lampa E, Rosatti F, Ottava R. Research on heterocyclic- compounds.10. Imidazo[1,2-a]pyrazine derivatives - synthesis and anti-inflammatory activity. Farmaco, Ed Sci 1981;36:61-80.
25. Rimoli MG, Avallone L, De Caprariis P, Luraschi E, Agabeygnente E, Filippelli W, Berrino L, Rossi F. Research on heterocyclic compounds. XXXVII. Synthesis and antiinflammatory activity of methyl-substituted imidazo[ 1,2-a]pyrazine derivatives. Eur J Med Chem 1997;32: 195-203. (Pubitemid 27154290)
26. Yale HL,Losee K,Martins J, HolsingM,PerryMF, Bernstein J. Chemotherapy of experimental tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related compounds. J Am Chem Soc 1953;75:1933-1942.
27. Turan-Zitouni G, Kaplancikli ZA, Güven K. N-(chroman-4- ylidene)aryloxyacetohydrazones: Synthesis and antimicrobial activity. Farmaco 1997;52:631-633.
28. NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2nd ed. Wayne, Pa: NCCLS; 2002., NCCLS document M27-A2 [ISBN 1-56238-469-4].
29. Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997;41:1004-1009.